Timolol eye drops (Timoptic) are a beta-adrenergic blocking agent used topically to reduce elevated intraocular pressure, supplied as 0.25% and 0.5% solutions that are stored at room temperature.
M Care Exports supplies timolol maleate eye drops, sold as Timoptic in the US and Timoptol in the UK, and the bimatoprost + timolol combination, to hospital pharmacies, ophthalmology units, licensed importers and tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. If you are looking for timolol 0.25% or 0.5%, send the strength, bottle size, quantity and destination, and we quote per destination.
Timolol exporter and bulk supplier from India.
"We need a partner for timolol eye drops" is a typical request from a hospital pharmacy or a ministry tender desk. M Care is a merchant-exporter: we offer originator or regulator-registered brands and Indian-made lines, and we confirm which one your destination's registration route accepts before quoting. The landed price of a timolol line depends on the strength (0.25% or 0.5%), the bottle size, the quantity, whether you want the plain solution or a combination such as bimatoprost + timolol, and the registration route and import licence in the destination. The US and UK labels store timolol eye drops at room temperature, not in a refrigerator, so freight and Incoterms are simpler than for a biologic, but the UK SmPC says to discard the solution 28 days after opening, so remaining shelf life at arrival matters for tenders. Our own catalogue includes Indian-made lines such as Timolol 0.5% Iotim Eye Drop and Timolol maleate 0.5% Timobrex 5 ml Eye Drops, and a bimatoprost (0.3 mg/ml) + timolol (5 mg/ml) line sold as Careprost plus. We do not state that any of these Indian brands is registered in a given destination. Oral timolol is outside this page.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Non-selective beta-adrenergic receptor blocking agent, sourced and documented for export.
Timolol maleate is a beta1 and beta2 (non-selective) adrenergic receptor blocking agent, in the words of the US label. The US Timoptic label (Bausch & Lomb) indicates it in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma, as 0.25% (2.5 mg/mL timolol) and 0.5% (5 mg/mL timolol) sterile ophthalmic solution with benzalkonium chloride 0.01% as preservative. The label lists a 5 mL bottle for 0.25% and 5 mL and 10 mL bottles for 0.5%, and says to store at 15 to 25 °C, protected from freezing and light. The UK SmPC for Timoptol (Santen) covers the reduction of elevated intra-ocular pressure in patients with ocular hypertension, patients with chronic open-angle glaucoma including aphakic patients, and some patients with secondary glaucoma. It gives a 5 ml bottle, a 36-month shelf life, storage not above 25 °C with the bottle in the outer carton to protect from light, and discard 28 days after opening. The WHO Model List of Essential Medicines (23rd list, 2023) includes timolol as eye drops, 0.25% and 0.5% (as hydrogen maleate). The combination Ganfort (bimatoprost 0.3 mg/ml and timolol 5 mg/ml, AbbVie Deutschland GmbH & Co. KG) received its EU marketing authorisation on 19 May 2006 for adults with open-angle glaucoma or ocular hypertension who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues.
Active ingredient
Timolol maleate. Non-selective beta-adrenergic receptor blocking agent.
Forms and strengths
0.25% eye drops, solution (2.5 mg/mL timolol); 0.5% eye drops, solution (5 mg/mL timolol); 0.3 mg/mL bimatoprost + 5 mg/mL timolol eye drops, solution (combination).
Indications
Timolol maleate eye drops, a non-selective beta-adrenergic receptor blocking agent used topically to reduce elevated intraocular pressure in ocular hypertension and open-angle glaucoma, also supplied in combination with bimatoprost.
Administration
Ophthalmic. Eye drops, solution.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers are hospital pharmacists in ophthalmology and glaucoma services, MoH and hospital tender desks, and licensed importers and distributors internationally. Typical enquiries read "I'm looking for timolol 0.5% eye drops for a hospital tender" or "We need a partner for bimatoprost and timolol eye drops". Each destination sets its own route, for example the Emirates Drug Establishment (EDE) in the UAE, NAFDAC in Nigeria and the MHRA in the UK, and we align the offer with the registration route and import licence before quoting. M Care supplies both originator or regulator-registered brands and Indian-made lines. Whether a destination accepts a given line, or needs a registered product or a named-patient or unlicensed import, depends on the regulator, and M Care Exports confirms the route per enquiry.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on timolol.
Check the strength and the indication before you build a pack list. The US label gives a usual starting dose of one drop of 0.25% in the affected eye or eyes twice a day, changing to one drop of 0.5% twice a day if the clinical response is not adequate. It says to check intraocular pressure after approximately 4 weeks, and if the pressure is maintained at satisfactory levels, the schedule may be changed to one drop once a day. The UK SmPC reads similarly and notes that nasolacrimal occlusion or closing the eyelids for 2 minutes reduces systemic absorption. Timolol is absorbed systemically, and both labels list contraindications including bronchial asthma or a history of it, severe chronic obstructive pulmonary disease, sinus bradycardia, second- or third-degree atrioventricular block (the UK SmPC adds: not controlled with a pacemaker), overt cardiac failure and cardiogenic shock. Benzalkonium chloride is the preservative, and both labels say to remove contact lenses before instillation and wait 15 minutes before reinserting them. Both labels say the concomitant use of two topical beta-adrenergic blocking agents is not recommended. For in-use life, the UK SmPC says to discard the solution 28 days after opening, while the US label says that after opening Timoptic can be used until the expiration date on the bottle, so follow the label of your destination.
The documentation pack a regulator actually asks for.
Timolol eye drops are a room-temperature line: the US label says to store at 15 to 25 °C and protect from freezing and light, and the UK SmPC says not to store above 25 °C and to keep the bottle in the outer carton to protect from light. Drugs@FDA lists Timoptic 0.25% and 0.5% under NDA 018086 with Bausch and Lomb Inc as the sponsor, and DailyMed also lists timolol maleate ophthalmic solution under ANDA, including labels for Sandoz Inc., so generic timolol eye drops are approved in the US. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator asks for it. For Indian-made lines, the certificate of pharmaceutical product, the WHO-GMP certificate and the manufacturing licence are issued by the State Licensing Authority (the state drug regulator), and a CoPP is valid for the period its issuer prints on it. We state the source and status of each line before quoting. M Care is a merchant-exporter and makes no manufacturing claim.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside timolol.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for timolol.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Timolol supply, the specific questions.
What sets the price of Timoptic eye drops for an importer?
We do not publish prices. The landed cost of timolol eye drops depends on whether you want the originator brand or a regulator-registered or Indian-made line, the strength (0.25% or 0.5%), the bottle size, the quantity, the registration route in your destination and the Incoterms. The US and UK labels store timolol at room temperature, so refrigerated freight is not part of the quote. M Care Exports quotes per destination once you send the strength, pack, volume and country.
What is the generic name of Timoptic?
The generic (non-proprietary) name is timolol, supplied as timolol maleate. The US Timoptic label describes 0.25% as 2.5 mg/mL timolol and 0.5% as 5 mg/mL timolol. The WHO Model List of Essential Medicines (2023) lists timolol as eye drops, 0.25% and 0.5% (as hydrogen maleate). Timoptic is a Bausch & Lomb trademark in the US, and Timoptol is the Santen product on the UK emc.
Is there a Timoptic generic, and who makes it?
In the US, yes. DailyMed lists timolol maleate ophthalmic solution under ANDA, for example the Sandoz Inc. labels (ANDA074261 for 0.25% and ANDA074262 for 0.5%), manufactured by Alcon Laboratories, Inc. for Sandoz, alongside the Timoptic label from Bausch & Lomb. For the EU, the UK and other destinations, ask us which timolol lines are registered there. M Care supplies originator or regulator-registered brands and Indian-made lines, and confirms the right line per destination.
What is the Timoptic dose and how is it stored?
The US label gives a usual starting dose of one drop of 0.25% in the affected eye or eyes twice a day, changing to one drop of 0.5% twice a day if the clinical response is not adequate. If intraocular pressure is maintained at satisfactory levels when checked after approximately 4 weeks, the schedule may be changed to one drop once a day. The US label says to store at 15 to 25 °C and protect from freezing and light. The UK SmPC says not above 25 °C in the outer carton, with a 36-month shelf life and discard 28 days after opening. Follow the label of your destination.
Do you supply bimatoprost + timolol eye drops, and how does Ganfort compare?
Yes. Our catalogue lists an Indian-made bimatoprost (0.3 mg/ml) + timolol (5 mg/ml) line, Careprost plus, and M Care also quotes originator or regulator-registered brands. Ganfort (bimatoprost 0.3 mg/ml and timolol 5 mg/ml) is authorised in the EU, with AbbVie Deutschland GmbH & Co. KG as marketing authorisation holder, for adults with open-angle glaucoma or ocular hypertension who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues. Plain timolol contains a single beta-blocking agent; the combination adds bimatoprost. We do not state that any Indian brand is registered in a given destination, so confirm the route with us before you tender.
Which markets can you supply timolol eye drops into, and what do I need to import them?
M Care Exports supplies hospitals, licensed importers, distributors and government tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. Every destination has its own rules. In the UAE, registration sits with the Emirates Drug Establishment (EDE), in Nigeria with NAFDAC, in the UK with the MHRA. Whether a given line is registered, or needs a named-patient or unlicensed import, depends on the regulator, and M Care confirms it per enquiry. See also the ophthalmology range.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.
